Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Current Vascular Pharmacology|June 3, 2009
ErbB targeted drugs and angiogenesisErika Iivanainen, Klaus EleniusMicroscopy Research and Technique|December 25, 2002
Endothelial cell-matrix interactionsErika Iivanainen, Veli-Matti Kähäri, Jyrki Heino, et al.Microvascular Research|July 15, 2009
The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vesselsErika Iivanainen, Susanna Lauttia, Na Zhang, et al.Experimental Cell Research|May 15, 2007
Intra- and extracellular signaling by endothelial neuregulin-1Erika Iivanainen, Ilkka Paatero, Satu-Maria Heikkinen, et al.Molecular Medicine (Cambridge, Mass.)|July 12, 2007
Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patientSaara Ihalainen, Rabah Soliymani, Erika Iivanainen, et al.Recent Patents on DNA & Gene Sequences|December 17, 2008
ErbB4 and its isoforms: patentable drug targets?Ilkka Paatero, Klaus EleniusFuture Oncology (London, England)|December 22, 2009
Potential of ErbB4 antibodies for cancer therapyMaija Hollmén, Klaus EleniusOncogene|September 1, 2018
Gamma-secretase-dependent signaling of receptor tyrosine kinasesJohannes A M Merilahti, Klaus EleniusFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factorErika Iivanainen, Lassi Nelimarkka, Varpu Elenius, et al.The Journal of Biological Chemistry|June 29, 2004
Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1Varpu Elenius, Martin Götte, Ofer Reizes, et al.Pageof 8